Volume 98
Private Law 98–46
Providing for an extension until April 21, 1992, of five patents relating to oral hypoglycemic drugs of the sulfonylurea class.
Approved October 19, 1984
Statutory text
An Act
Providing for an extension until April 21, 1992, of five patents relating to oral hypoglycemic drugs of the sulfonylurea class.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
That the Secretary of Commerce, acting through the Commissioner of Patents and Trademarks, shall, when the following patents (relating to oral hypoglycemic drugs of the sulfonylurea class) expire, extend such patents until April 21, 1992, with all the rights pertaining thereto:
Patent numbered 3,426,067.
Patent numbered 3,454,635.
Patent numbered 3,507,954.
Patent numbered 3,507,961.
Patent numbered 3,669,966.
Approved October 19, 1984.